Foghorn Therapeutics (FHTX) Asset Utilization Ratio (2020 - 2026)

Foghorn Therapeutics' Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.13 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 55.06% year-over-year to 0.13; the TTM figure through Mar 2026 stood at 0.13 (up 55.06% YoY), while the FY2025 annual figure was 0.13, up 61.66% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.13, down from 0.15 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.15 in Q4 2025, with the low at 0.01 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.09 (2025), against an average of 0.08.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio surged 1126.68% in 2022, then tumbled 33.04% in 2024.
• Foghorn Therapeutics' Asset Utilization Ratio stood at 0.05 in 2022, then jumped by 148.61% to 0.11 in 2023, then sank by 33.04% to 0.08 in 2024, then soared by 100.98% to 0.15 in 2025, then slipped by 12.42% to 0.13 in 2026.
• Business Quant data shows FHTX's Asset Utilization Ratio at 0.13 in Q1 2026, 0.15 in Q4 2025, and 0.11 in Q3 2025.